Neil D. Almeida

Dr. Neil D. Almeida


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
NANeil D. Almeida
Neil D. Almeida
CKCathleen Kuo
Cathleen Kuo
TSTyler Vincent Schrand
Tyler Vincent Schrand
JRJulia Rupp
Julia Rupp
VMVenkatesh S Madhugiri
Venkatesh S Madhugiri
DPDheerendra Prasad
Dheerendra Prasad
Background/Objectives: To determine the impact of stereotactic radiosurgery on outcomes of metastatic breast cancer with intracranial metastases. Methods: We systematically searched the PubMed and EMBASE databases for studies published between 1 January 1990 and 1 August 2024. Primary research articles evaluating the outcomes of stereotactic radiosurgery on intracranial metastases from breast cancer were included. Adverse events were defined as leptomeningeal disease, radiation necrosis, seizure, and headache. The pooled estimate was calculated using the DerSimonian and Laird approach. Results: Sixteen studies encompassing 1228 patients met the inclusion criteria. Our analysis revealed a median survival duration of 13.1 ± 3.8 months and a pooled 1-year overall survival rate of 53.1% after SRS treatment. There was a 29% local recurrence rate at 1 year and a 35% overall distant recurrence rate. In addition, our analysis found a relatively low rate of acute adverse events at 15.5%. Conclusions: SRS demonstrates promising efficacy and safety in managing intracranial metastases from breast cancer, with a favorable toxicity profile.

28 April 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
VGVictor Goulenko
Victor Goulenko
SSSarthak Sinha
Sarthak Sinha
BGBabar Gulzar
Babar Gulzar
VMVenkatesh S Madhugiri
Venkatesh S Madhugiri
NANeil D. Almeida
Neil D. Almeida
DPDheerendra Prasad
Dheerendra Prasad
Purpose: Postoperative Gamma Knife Radiosurgery (GKRS) to resection cavities is standard for intracranial metastases, but the dynamics of these cavities after treatment and their relationship to local control remain incompletely defined. Methods: We retrospectively reviewed 98 patients with 98 resection cavities treated with single- or hypofractionated Gamma Knife radiosurgery (GKRS) between 2011 and 2025. Cavity volumes were segmented from serial contrast-enhanced MRI and compared with GKRS planning volumes. Longitudinal changes in log-transformed volumes were modeled using linear mixed-effects regression. Local recurrence–free survival (LRFS) and overall survival (OS) were estimated using Kaplan–Meier analysis, and associations with outcomes were tested using Cox proportional hazards models. Results: Median imaging follow-up was 9.1 months (IQR 4.9–16.5), and cavities showed significant volume reduction over time (β = −0.031 ln[cc]/month, p < 0.001). Modeling indicated a nonlinear pattern, with greater reduction early and relative stabilization thereafter. At 12 and 24 months, actuarial local control was 74.5% and 62.5%, respectively; median LRFS was 49.8 months. Volume regression occurred in both recurrent and non-recurrent groups, and the interaction between recurrence status and time was nonsignificant. Recurrence rates did not differ between single- and hypofractionated GKRS across preoperative volume strata. Higher Karnofsky performance status at surgery and at GKRS correlated with improved OS and smaller cavity volumes. Conclusions: Cavities treated with GKRS showed consistent involution over time, most pronounced early after treatment. Volumetric change alone was not associated with local control; interpretation of local failure requires dosimetric and target-definition context.

23 January 2026 in Surgical Neurology International
Verified
Journal Article
Open access
NANeil D. Almeida
Neil D. Almeida
SSSarthak Sinha
Sarthak Sinha
MFMengyu Fang
Mengyu Fang
DSDaniel Sullivan
Daniel Sullivan
JRJulia Rupp
Julia Rupp
DPDheerendra Prasad
Dheerendra Prasad
Background: Meningiomas are the most common intracranial tumor. Ionizing radiation has been implicated in the pathogenesis of radiation-induced meningiomas (RIM). Compared to spontaneous meningiomas, RIM are a clinically aggressive entity and are more likely to develop clinical and radiologic progression. Methods: Systematic searches of Medline, Embase, and Cochrane Central Register of Controlled Trials were performed. Pooled data were used to calculate rates of survival, tumor control, and adverse events. Results: Thirty studies met the final inclusion criterion within this meta-analysis. In total, these studies reported on 927 RIMs in 825 patients. Patients were grouped by whether they received cranial radiotherapy ([CRT]; n = 555 patients) or scalp radiotherapy for tinea capitis ([TC]; n = 270 patients). The median dose prescribed to the CRT and TC groups was ~30 Gy and 1.5 Gy, respectively. The radiation interval to meningioma development between CRT and TC groups were 21.54 and 40.49 years, respectively ( P < 0.0001). Twenty-six studies reported a 1-year overall survival rate, with a pooled survival rate of 95.46% (95% confidence interval [CI]: 92.31–97.82%, I2 = 51.9%, P = 0.0012). One-year progression-free survival was reported by 9 studies, with a pooled rate of 99.71% (95% CI: 97.62–100.00%, I 2 = 3.3%, P = 0.4076). From two studies, the pooled 1-year local recurrence rate was 16.54% (95% CI: 0.00–34.06%, I 2 = 0.0%, P = 0.5918), while the overall pooled local recurrence rate was 27.35% (95% CI: 17.98–36.73%, I 2 = 74.5%, P < 0.0001) from 23 studies. Conclusion: High- and low-dose cranial radiation therapy can differentially influence the latency and grade of RIM, with higher dose CRT associated with earlier onset and more atypical tumors RIM screening may be warranted in individuals with an early exposure to cranial radiation given the increased risk of developing secondary neoplasms. These findings support structured long-term magnetic resonance imaging surveillance for survivors of childhood cranial irradiation, with risk adapted follow-up protocols to enable earlier detection and management.

27 August 2025 in Journal of Clinical Neuroscience
Verified
Journal Article
Open access
VGVictor Goulenko
Victor Goulenko
SSSarthak Sinha
Sarthak Sinha
VMVenkatesh S Madhugiri
Venkatesh S Madhugiri
NANeil D. Almeida
Neil D. Almeida
RPRobert J. Plunkett
Robert J. Plunkett
DPDheerendra Prasad
Dheerendra Prasad
Orbital cavernous hemangiomas (OCH) are rare benign vascular tumors that pose therapeutic challenges due to their proximity to critical visual structures. While surgical resection remains the standard of care, Gamma Knife radiosurgery (GKRS) has emerged as a minimally invasive alternative. However, the optimal fractionation strategy, single-session versus hypofractionated treatment, remains unclear. This review aims to evaluate the clinical and radiological outcomes of single-session versus hypofractionated GKRS for OCH through a systematic review, meta-analysis, and a complementary institutional case series. A systematic review was conducted following PRISMA guidelines and registered with PROSPERO (registration code:1061256). Databases were searched from inception through April 2025. Eligible studies reported outcomes of GKRS for OCH using either single-session or hypofractionated treatment. Meta-analyses were performed to compare (1) the proportion of patients with tumor volume reduction, (2) the mean percentage reduction in tumor volume, and (3) the proportion of patients with improvement in visual symptoms. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklists. Funnel plots and Egger's test were used to assess publication bias. Additionally, three institutional cases treated with GKRS were included to supplement the clinical context. Eleven studies comprising 117 patients were included, with an additional 3 patients from our institution. Tumor volume reduction was observed in 100 % of patients in the fractionated group and 89 % in the single-session group (p = 0.0853). The pooled mean percentage volume reduction was -2.65 % (95 % CI: -6.36 to 3.97) in the fractionated group and -2.85 % (95 % CI: -8.97 to 4.43) in the single-session group (p = 0.9572). Improvement in visual symptoms was seen in 80 % of patients in the fractionated group and 69 % in the single-session group (p = 0.4763). Funnel plots demonstrated minimal publication bias, except for a potential small-study effect in visual symptom outcomes. JBI assessment indicated moderate to high methodological quality across most studies. Both single-session and hypofractionated GKRS appear to be effective and safe treatment options for OCH, with comparable clinical outcomes. Hypofractionation may offer advantages in select patients with optic nerve proximity, though current evidence does not show statistically significant differences between approaches. Single-session GKRS remains a pragmatic and effective option in anatomically favorable cases and may be complemented by adaptive or rescue fractionation strategies when tumor response is suboptimal or recurrence is observed. Prospective multicenter studies with standardized outcome reporting are needed to define optimal treatment strategies.

3 July 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
NANeil D. Almeida
Neil D. Almeida
SSSarthak Sinha
Sarthak Sinha
MFMengyu Fang
Mengyu Fang
HCHarshini Cheruvu
Harshini Cheruvu
RTRoshan Tasgaonkar
Roshan Tasgaonkar
DPDheerendra Prasad
Dheerendra Prasad
Background: Brain metastases from renal cell carcinoma (RCC) are uncommon but clinically consequential. We evaluated survival, intracranial failure, lesion-level local failure, and MRI volumetric response after Gamma Knife radiosurgery (GKRS), including associations with systemic therapy exposure. Methods: We retrospectively identified patients treated with GKRS for intracranial RCC metastases (2001–2025). Systemic therapy exposure (TKI and/or immunotherapy) was captured time-agnostically. Overall survival (OS) and patient-level intracranial treatment failure were analyzed using Kaplan–Meier/Cox models. Lesion-level treatment failure was analyzed using clustered generalized estimating equations (GEE). Six-month volumetric response was assessed using an epsilon-stabilized log volume ratio ln{(V 6m +ϵ)/(V GKRS +ϵ)}, ε = 0.01. Results: Thirty-four patients (87 lesions) were treated; 22 deaths occurred. Overall survival was numerically longer among patients who received systemic therapy compared with those who did not, although this did not reach statistical significance (log-rank p = 0.058). In a parsimonious adjusted Cox model, TKI exposure was associated with improved OS (aHR 0.191; 95% CI 0.062–0.593; p = 0.004), as was higher KPS (HR 0.37 per 10-point increase; 95% CI 0.21–0.63; p < 0.001). Ten patient-level intracranial treatment failure events occurred, without significant differences by systemic therapy exposure. At the lesion level, 15/87 lesions failed; postoperative cavities had higher failure than intact lesions (71.4% vs. 12.5%; p = 0.001) and remained associated with failure after clustered adjustment (OR 9.92; 95% CI 1.44–68.27; p = 0.020). Dmax was not correlated with 6-month log volume ratio (ρ=−0.075; p = 0.535), but poorer 6-month volumetric response was associated with subsequent lesion failure ( p = 0.0023; clustered OR 2.84; 95% CI 1.16–6.96; p = 0.023). Conclusions: In RCC brain metastases treated with GKRS, postoperative cavities showed a higher observed rate of local failure than intact lesions, although this finding should be interpreted cautiously given the small number of cavity targets. While Dmax was not associated with early volumetric change, early 6-month volumetric trajectory was associated with subsequent local failure, suggesting a pragmatic imaging marker for risk-adapted surveillance and salvage planning. Systemic therapy exposure, particularly TKIs, was associated with OS in adjusted analysis, whereas intracranial treatment failure did not differ by systemic exposure in this cohort.

20 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SMSung Jun Ma
Sung Jun Ma
JVJas Virk
Jas Virk
TSTyler Vincent Schrand
Tyler Vincent Schrand
JGJasmin Gill
Jasmin Gill
NANeil D. Almeida
Neil D. Almeida
ASAnurag Kishor Singh
Anurag Kishor Singh
Background/Objectives: There is a varying need for nutritional support among head and neck cancer (HNC) patients. Unplanned hospitalization is frequent with definitive chemoradiation. However, the association of unplanned hospitalizations with cancer control outcomes and percutaneous endoscopic gastrostomy (PEG) tube placement is not well-understood. This study aims to evaluate the clinical outcomes stratified by unplanned hospitalizations and to identify the prognostic factors associated with unplanned hospitalizations. Methods: This retrospective cohort study included 657 HNC patients treated with definitive chemoradiation at a single institution between 2007 and 2023. Relevant clinical data were evaluated for unplanned hospitalizations, prophylactic vs. therapeutic PEG tube placement, and clinical outcomes. Multivariable, subgroup, and matched-pair analyses were performed to account for potential confounding variables. The main outcomes and measures used are overall survival (OS), progression-free survival (PFS), locoregional failure (LRF), distant failure (DF), and incidence of unplanned hospitalization. Results: Unplanned hospitalizations occurred in 190 (29%) patients, which were associated with worse OS (adjusted hazards ratio [aHR] of 2.07, 95% confidence interval [CI] of 1.53–2.81, p < 0.001) and progression-free survival (aHR 1.83, 95% CI 1.38–2.41, p < 0.001). However, hospitalizations were not associated with LRF or DF outcomes. Similar findings were noted on 180 matched pairs as well as subgroups stratified by p16 status. In addition, when compared to patients with a prophylactic PEG tube, therapeutic PEG tube placement was associated with a higher risk of hospitalization (adjusted odds ratio [aOR] of 1.96, 95% CI 1.10–3.54, p = 0.02), while those without PEG tubes were less likely to be hospitalized (aOR 0.48, 95% CI 0.27–0.86, p = 0.01). Conclusions: Unplanned hospitalization was an independent, adverse prognostic factor for poor survival, but not oncologic outcomes. Unplanned hospitalization incidence was largely driven by those who required a therapeutic PEG tube, while it was the lowest for those who never needed a PEG tube.